全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Masatoyo Nakajo , Yoriko Kajiya ...
来源:[J].European Journal of Nuclear Medicine and Molecular Imaging(IF 5.114), 2017, Vol.44 (13), pp.2158-2168Springer
摘要:This retrospective study was done to examine whether the heterogeneity in primary tumor F-18-fluorodeoxyglucose (18F-FDG) and 18F-3′-fluoro-3′-deoxythymidine (18F-FLT) distribution can predict prognosis of patients with colorectal cancer who ...
作者:Masatoyo Nakajo , Megumi Jinguji ...
来源:[J].Abdominal Radiology, 2017, Vol.42 (12), pp.2882-2889Springer
摘要:To retrospectively investigate the SUV-related and texture parameters individually and in combination for differentiating between F-18-fluorodeoxyglucose (FDG)-avid benign and metastatic adrenal tumors with PET/CT.
作者:Masatoyo Nakajo , Yoriko Kajiya ...
来源:[J].Abdominal Radiology, 2017, Vol.42 (4), pp.1210-1221Springer
摘要:The purpose of the study was to examine the diagnostic and prognostic values of 18F-fluorothymidine (FLT)-PET/CT for pancreatic cancer by comparing with 18F-fluorodeoxyglucose (FDG)-PET/CT.
作者:... Megumi Jinguji , Masatoyo Nakajo , Masayuki Nakajo
来源:[J].CardioVascular and Interventional Radiology(IF 2.138), 2014, Vol.37 (5), pp.1220-1225Springer
摘要:Abstract(#br) Purpose(#br)Transcatheter arterial embolization (TAE) with absolute ethanol is widely accepted as a therapeutic procedure for renal angiomyolipoma (AML). We aim to evaluate the split renal function before and after AE for renal AML by using 99m-technetium ( 99m...
作者:Masatoyo Nakajo , Megumi Jinguji ...
来源:[J].European Journal of Nuclear Medicine and Molecular Imaging(IF 5.114), 2017, Vol.44 (2), pp.206-214Springer
摘要:Abstract(#br) Purpose(#br)This retrospective study was done to examine whether the heterogeneity in primary tumour F-18-fluorodeoxyglucose ( 18 F-FDG) distribution can predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy (CRT)...
作者:Masatoyo Nakajo , Megumi Jinguji ...
来源:[J].Molecular Imaging and Biology(IF 3.095), 2019, Vol.21 (4), pp.771-780Springer
摘要:Abstract(#br) Purpose(#br)To examine whether the heterogeneous texture parameters in primary tumor can predict prognosis of patients with non-small cell lung cancer (NSCLC) received surgery after 2-deoxy-2-[ 18 F]fluoro-D-glucose ([ 18 F]FDG) positron emission tomography (PE...
作者:Masatoyo Nakajo , Atsushi Tani ...
来源:[J].European Journal of Nuclear Medicine and Molecular Imaging(IF 5.114), 2018, Vol.45 (10), pp.1661-1671Springer
摘要:Abstract(#br) Purpose(#br)The purpose of this study was to evaluate therapeutic response to neoadjuvant chemotherapy (NAC) and predict breast cancer recurrence using Positron Emission Tomography Response Criteria in Solid Tumors (PERCIST).(#br) Materials and methods(#br)Fift...
作者:Masatoyo Nakajo , Masayuki Nakajo ...
来源:[J].European Radiology(IF 3.548), 2014, Vol.24 (12), pp.3199-3209Springer
摘要:Abstract(#br) Objective(#br)To examine correlations of 18 F-fluorothymidine (FLT) uptake with pathological tumour size and immunohistochemical Ki-67, and thymidine kinase 1 (TK-1) expressions in primary and metastatic node colorectal cancer foci.(#br) Methods(#br)Thirty prim...
作者:Masatoyo Nakajo , Megumi Jinguji ...
来源:[J].European Radiology(IF 3.548), 2015, Vol.25 (12), pp.3696-3705Springer
摘要:Abstract(#br) Objective(#br)To compare F-18-fluorodeoxyglucose (FDG) and F-18-fluorothymidine (FLT) PET/CT examinations for differentiating between benign and malignant adrenal tumours.(#br) Methods(#br)Thirty lipid-poor benign and 11 malignant tumours of 40 patients were in...
作者:... Takao Minamizawa , Masatoyo Nakajo , Masayuki Nakajo
来源:[J].Annals of Nuclear Medicine(IF 1.41), 2014, Vol.28 (10), pp.986-993Springer
摘要:Abstract(#br) Objective(#br)Radioiodide is commonly used to diagnose and treat hyperthyroidism and thyroid carcinoma. However, we could not find any experimental data that strictly compared the biodistribution and thyroid uptake of radioactive iodide between the oral and int...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×